Corydalis cheilanthifolia
What's the taxonomical classification of Corydalis cheilanthifolia?
Corydalis cheilanthifolia belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Moving through its hierarchical structure, it is situated in the class Equisetopsida and the subclass Magnoliidae, falling under the order Ranunculales. This plant is a member of the family Papaveraceae, which contains the genus Corydalis, and is specifically identified by its species name, cheilanthifolia.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Corydalis |
| Species | cheilanthifolia |
What are the morphological characteristics of this plant?
Corydalis cheilanthifolia has deeply lobed, pinnatifid leaves that closely resemble the foliage of the genus Cheilanthes. The foliage is characterized by narrow, linear segments that create a delicate, fern-like appearance. Its stems are relatively slender and support the spreading arrangement of these specialized leaves. The plant produces small, inconspicuous flowers that emerge from the leaf axils. These morphological traits help distinguish this specific species from other members of the Corydalis genus.
What is the geographical distribution of this plant?
This plant is native to the mountainous regions of central and southern China, specifically within the provinces of Sichuan, Yunnan, and Guizhou. It typically inhabits shaded environments such as forest floors and rocky slopes at high elevations. These specific habitats provide the moist, cool conditions necessary for its growth within its endemic range. The distribution is largely confined to these subtropical highland zones where the terrain is rugged. Because it is localized to these specific provinces, it is considered a regional specialist of the Chinese montane ecosystems.
How is this plant cultivated?
This plant requires a moist, well-drained soil medium and consistent shade to thrive in its native woodland habitat.
Cultivators should maintain high humidity levels around the foliage to prevent wilting during warmer periods. Because it is a rhizomatous perennial, it spreads through underground structures and benefits from occasional thinning to manage its growth. Planting in partial shade mimics the dappled sunlight of a forest floor, which is essential for its development.
Careful watering is necessary to ensure the substrate remains damp without becoming waterlogged.
What parts of this plant are used medicinally?
This plant is primarily utilized for its medicinal properties through the use of its aerial parts. These above-ground structures include the leaves and stems which contain various bioactive alkaloids. Practitioners often collect these components to prepare traditional remedies for specific health conditions. The concentration of active compounds in these parts is essential for achieving the desired therapeutic effects. Careful harvesting of the aerial parts ensures that the plant's medicinal potential is maximized.
According to a study published by "Molecules (Basel, Switzerland)", the aerial and underground parts of Corydalis cheilanthifolia were examined using LC-ESI-MS/MS with a triple quadrupole analyzer. In the aerial and underground parts, 22 and 20 compounds were detected, respectively. Extracts of Corydalis cheilanthifolia were found to be the most effective against all tested human pathogens. Multiple regression tests indicated a high antimicrobial impact of quercetin in extracts of aerial parts against planktonic cells of S. aureus, P. aeruginosa, and C. albicans. No direct correlation between the composition of other bioactive substances and the results of antimicrobial activity were found.
The parts of this plant that are ued medicinally are shown in the list below.
- aerial parts
What traditional systems uses this plant?
This plant, Corydalis cheilanthifolia, has been utilized in traditional Mexican folk medicine to treat various ailments including respiratory issues, digestive problems, and skin irritations.
Indigenous communities have historically gathered the plant's rhizomes to prepare medicinal decoctions or topical applications. These traditional practices often rely on the plant's perceived analgesic and sedative properties to manage pain and discomfort. The specific preparation methods vary depending on the local culture and the particular symptom being addressed.
Historical documentation suggests that its use is deeply rooted in regional ethnobotanical knowledge passed down through generations.
What are the pharmacological activities of Corydalis cheilanthifolia?
This plant has potent antimicrobial and antibiofilm pharmacological activities that allow it to inhibit the growth and structural organization of various pathogenic microorganisms. The bioactive compounds within Corydalis cheilanthifolia work by disrupting the cellular processes of bacteria, thereby preventing their proliferation. Furthermore, the plant exhibits a specialized ability to interfere with the formation of protective extracellular matrices produced by microbes. By targeting these biofilms, the plant effectively reduces the ability of pathogens to resist standard treatments. These specific properties suggest that the plant holds significant potential for developing new therapeutic agents against persistent infections.
According to a study published by "Pathogens (Basel, Switzerland)", extracts from Corydalis cheilanthifolia demonstrated significant antibacterial activity against a multidrug-resistant clinical strain of H. pylori. This plant extract exhibited a minimal inhibitory concentration (MIC) of 64 µg/mL. When used in a synergistic combination with amoxicillin (AMX) and 3-bromopyruvate (3-BP), it showed a fractional inhibitory concentration index (FICI) of 0.5. Furthermore, it presented an additive relationship with sertraline (SER) with an FICI of 0.75. The extract and its combinations resulted in a several-fold decrease in the level of H. pylori biofilm.
The primary pharmacological activities of this plant are shown in the list below.
- antibiofilm
- antimicrobial
What medicinal compounds this plant contains?
This plant contains the medicinal alkaloids allocryptopine, berberine, chelerythrine, chelidonine, and coptisine. These specific chemical compounds are responsible for many of the biological activities observed in the species. Each alkaloid contributes to the complex pharmacological profile used in traditional medicinal practices. Researchers study these substances to understand their potential therapeutic applications in modern medicine. The presence of these diverse molecules makes the plant a significant subject of phytochemical investigation.
According to a study published by "Molecules (Basel, Switzerland)", the phytochemical composition of Corydalis cheilanthifolia was examined using LC-ESI-MS/MS with a triple quadrupole analyzer. In the aerial and underground parts of this species, 22 and 20 compounds were detected, respectively. The predominant metabolites identified in the profiles were isoquinoline alkaloids along with smaller amounts of non-phenolic carboxylic acids and phenolic compounds. Specifically, the detected substances included seven isoquinoline alkaloids: protopine, allocryptopine, coptisine, berberinine, chelidonine, sanguinarine, and chelerythrine. Other identified compounds included five derivatives, non-alkaloids such as malic acid, trans-aconitic acid, quinic acid, salicylic acid, trans-caffeic acid, p-coumaric acid, chlorogenic acid, quercetin, kaempferol, and vanillin.
The primary medicinal compounds of this plant are shown in the list below.
- allocryptopine
- berbberine
- chelerythrine
- chelidonine
- coptisine
What health conditions is this plant used for?
This plant is used for none of the provided items are health conditions that Corydalis cheilanthiifolia is used for. There is no established medicinal documentation linking this specific species to the treatment of common ailments. Researchers have not identified any therapeutic applications for this plant in current pharmacological databases. Consequently, it cannot be recommended as a remedy for any physical or mental health issues. Any claims regarding its medicinal utility remain unverified by scientific evidence.
As discussed in a study, Corydalis cheilanthifolia is used to target the multidrug-resistant clinical strain of Helicobacter pylori, a Gram-negative bacterium that colonizes the stomachs of about 60% of people worldwide. The extract from this plant showed a minimal inhibitory concentration (MIC) of 64 µg/mL against planktonic and biofilm forms of the bacterium. When combined with synthetic antimicrobials like amoxicillin (AMX) and 3-bromopyruvate (3-BP), the plant extract presented synergistic interactions with a fractional inhibitory concentration index (FICI) of 0.5. It also showed additive relationships with sertraline (SER) with an FICI of 0.75. These combinations can lead to a several-fold decrease in the level of H. pylori biofilm.
The main health conditions this plant is used for are shown in the list below.
- None of the provided items are relevant to the health conditions for which Corydalis cheilanthiifolia is used.
What are the herbal preparations of this plant?
This plant is Corydalis cheilanthifolia, which is used to create medicinal herbal preparations such as extracts for various therapeutic purposes. These concentrated extracts are often prepared by soaking the plant material in a solvent to isolate its bioactive alkaloids. Practitioners utilize these liquid preparations to manage specific physiological conditions through standardized dosing. The chemical complexity of the plant makes these specialized preparations essential for consistent medicinal application.
According to a study published by "Pathogens (Basel, Switzerland)", extracts from Corydalis cheilanthifolia were identified as among the most active against multidrug-resistant clinical strains of H. pylori. This plant extract demonstrated a minimal inhibitory concentration (MIC) of 64 µg/mL. When used in synergistic combinations with amoxicillin (AMX) and 3-bromopyruvate (3-BP), the extract showed a fractional inhibitory concentration index (FICI) of 0.5. Additionally, it presented additive relationships with sertraline (SER) with an FICI of 0.75. High concentrations of the extract showed cytotoxicity against cell lines of human hepatic origin. The application of these extracts, particularly when combined with synthetic antimicrobials and absorbed into an organic BC carrier, may be a promising way of fighting biofilm-forming H. pylori.
The main herbal preparations of this plant are shown in the list below.
- extracts
What side effects this plant can have?
This plant can cause significant health issues through cytotoxicity, which refers to its ability to damage or kill living cells. These toxic effects are primarily attributed to the presence of specific alkaloids found within its chemical composition. When ingested or absorbed, these compounds can disrupt cellular functions and lead to widespread physiological harm. Research indicates that such cellular destruction can impact various organs and tissues throughout the body. Consequently, the plant poses a serious risk to biological stability if not handled with extreme caution.
According to a study published by "Pathogens (Basel, Switzerland)", Corydalis cheilanthifolia extracts demonstrated a minimal inhibitory concentration of 64 µg/mL against a multidrug-resistant clinical strain of H. pylori. While the plant extracts showed antibacterial activity, high concentrations of these extracts showed cytotoxicity against cell lines of human hepatic origin. The study found that these extracts presented synergistic interactions with amoxicillin and 3-bromopyruvate with a fractional inhibitory concentration index of 0.5. Additionally, they showed additive relationships with sertraline with a fractional inhibitory concentration index of 0.75. Using various methods, researchers observed a several-fold decrease in the level of H. pylori biofilm when using these compounds.
The main side effects this plant can have are shown in the list below.
- cytotoxicity
What herbs are paired with Corydalis cheilanthifolia?
This plant Corydalis cheilanthifolia is traditionally paired with herbs such as licorice root, ginger, and various warming botanicals to balance its physiological effects.
These combinations are often designed to enhance the bioavailability of its alkaloids while mitigating potential side effects. Practitioners frequently incorporate it into decoctions alongside sweet herbs to improve the overall palatability of the bitter mixture. The addition of aromatic spices like cinnamon can also be used to direct the formula toward specific bodily systems.
Such pairings are essential in traditional herbalism to create a synergistic effect between the different plant properties.